NOT JUST ANALYTICS. IT'S BIOPROGNOSIS.
DEAD

Serial Number

97145964

Owner

Renalytix AI, Inc.

Attorney

Susan Piascik Christoff

Filing Date

Nov 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NOT JUST ANALYTICS. IT'S BIOPROGNOSIS. Trademark

Serial Number: 97145964

NOT JUST ANALYTICS. IT'S BIOPROGNOSIS. is a trademark filed by Renalytix AI, Inc. on November 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Renalytix AI, Inc. (23 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 03

Trademark Details

Filing Date

November 29, 2021

Registration Date

Not Registered

Published for Opposition

May 31, 2022

Goods & Services

Providing online journals, namely, blogs in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver diseases, heart health, heart diseases, and the use of artificial intelligence for medical analysis; entertainment, information, and education services, namely, providing podcasts in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver disease treatments, heart health, heart disease treatments, and the use of artificial intelligence for medical analysis; video production; arranging and conducting of conferences, symposia, and educational special events in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver disease treatments, heart health, heart disease treatments, and the use of artificial intelligence for medical analysis; Educational services, namely, conducting informal on-line programs in the fields of health and medical information, kidney health, kidney disease, kidney disease treatments, liver health, liver disease treatments, heart health, heart disease treatments, and the use of artificial intelligence for medical analysis, and printable materials distributed therewith

Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in kidney, heart, and liver health testing and disease prediction

Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease

Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and test trips, and medical sample tubes, vials, and test strips for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health

Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; research and development services in the field of antibodies relating to kidney, heart, and liver health; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis in the field of kidney, heart, and liver health and kidney, heart, and liver disease

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 2, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 1, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 13, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 11, 2023 EX1G
SOU EXTENSION 1 FILED
May 11, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 11, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
NEW NOA TO ISSUE
Oct 17, 2022 NEWN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2022 NOAM
NOTICE OF ALLOWANCE CANCELLED
Jul 26, 2022 IUCN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 14, 2022 XAEC
ASSIGNED TO LIE
Apr 14, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 14, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 14, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 14, 2022 CNEA
ASSIGNED TO EXAMINER
Mar 30, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2021 NWOS
NEW APPLICATION ENTERED
Dec 2, 2021 NWAP